View Now | Clinical Outcome Assessments: Does one size fit all?
Join C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform and its Rare Disease Clinical Outcome Assessment Consortium executive leaders Alexandre Betourne and Lindsey Murray for this new webinar Clinical Outcome Assessments: Does one size fit all?
The webinar will cover:
- The complexity of identifying appropriate clinical outcome assessments for rare disease clinical trials
- An overview of the Rare Disease Clinical Outcome Assessment Consortium
- The synergies between RDCA-DAP and RD-COAC, and how data aggregation provides opportunities to refine, select and interpret COAs across rare diseases.
When: Apr 27, 2023 | 12 PM ET
Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 54% funded by the FDA/HHS, totaling $19,436,549, and 46% funded by non-government source(s), totaling $16,373,368. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. Government.